Search

everythinglearnresearchcommunity

for

Search:↓

Sunlight simulation causes skin inflammation, with different skin types reacting at different levels of exposure.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Skin reactions from cancer treatments might predict how well the treatments work.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Scoring systems help doctors assess and treat skin diseases effectively.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The new skin model can predict how chemicals might cause skin allergies.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

SII is a useful and affordable tool to assess and monitor alopecia areata.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Various drugs caused different skin reactions, including allergic and inflammatory responses.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.